U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07087067) titled 'Aspirin Role for Preventing Clinical Risks Related to High Risk Pregnancy' on June 09.
Brief Summary: Preeclampsia and its related consequences significantly contribute to maternal and neonatal morbidity and mortality, particularly in high-risk pregnancies. Low-dose aspirin has shown promise in reducing these risks, particularly when initiated early in gestation. This study evaluated the effectiveness of 75 mg aspirin, started before 12 weeks of gestation, in reducing adverse pregnancy outcomes among high-risk pregnant women.
A randomized controlled trial was undertaken with high-risk pregnant women. Pregnant women were randomized ...